Data focuses on veterans who have poorly controlled diabetes, and whether the intervention of self-care management skills works as compared to using traditional means of education.  

With the steady incline of diabetes rates, premature birth is being investigated as a possible culprit for the chronic disease. 

Blood glucose monitors – a breakthrough that followed urine tests and lasted over 50 years – may soon go into the museums, showing how patients with diabetes used to check their blood sugars.  

Glucocorticoid therapy is effective in reducing harm from many immune system disorders, but can also cause serious side effects. 

With the increase in lower limb amputations due to diabetes, researchers look into how specific racial groups manage nonpharmacological modalities in prevention.  

We were following up with a person with type 2 diabetes who was recently started on the new oral formulation of the GLP-1 receptor agonists semaglutide (Rybelsus®). This patient had a 12-year history of type 2 diabetes as well as several comorbidities that included hypertension, hyperlipidemia, obesity (BMI = 33 kg/m2), knee osteoarthritis, and hypothyroidism. The patient was previously resistant to initiating a GLP-1 receptor agonist due to his hesitancy toward self-injection. He agreed at his last primary care visit to start a trial of oral semaglutide to improve his glucose control and lose some weight....

How adipose tissue storage, which differs by gender, plays a role in the development and treatment of the disease. 

Are patients on board with new insulin delivery and glucose monitoring technology?

The MAG1C interventional study was a single-center, 26-week, phase 2a, to look at how Exenatide might benefit patients with type 1 diabetes. 

Current studies are showing that micro and macro complications begin at prediabetes.